Yonsei University

Yonsei University logo
πŸ‡°πŸ‡·South Korea
Ownership
Private
Established
1885-01-01
Employees
5K
Market Cap
-
Website
http://www.yonsei.ac.kr

Gemcitabine, Capecitabine, and Oxaliplatin as Second-Line Therapy in Treating Patients With Advanced Colorectal Cancer Previously Treated With Irinotecan

Phase 1
Conditions
First Posted Date
2007-07-04
Last Posted Date
2009-08-21
Lead Sponsor
Yonsei University
Target Recruit Count
56
Registration Number
NCT00496704
Locations
πŸ‡°πŸ‡·

Yonsei Cancer Center at Yonsei University Medical Center, Seoul, Korea, Republic of

Diurnal Intraocular Pressure and Peripapillary Retinal Blood Flow in Medically Controlled Open-Angle Glaucoma

Completed
Conditions
First Posted Date
2007-06-01
Last Posted Date
2007-06-01
Lead Sponsor
Yonsei University
Target Recruit Count
70
Registration Number
NCT00481208
Locations
πŸ‡°πŸ‡·

Severance Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of

Personality Characteristics and Compliance With Antiglaucoma Medication

Conditions
First Posted Date
2007-06-01
Last Posted Date
2007-06-01
Lead Sponsor
Yonsei University
Target Recruit Count
150
Registration Number
NCT00481494
Locations
πŸ‡°πŸ‡·

Severance Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of

The Effects of Exercise on Adipokine in Impaired Fasting Glucose or Impaired Glucose Tolerance Patients

Not Applicable
Conditions
First Posted Date
2007-05-11
Last Posted Date
2007-05-11
Lead Sponsor
Yonsei University
Target Recruit Count
182
Registration Number
NCT00472342
Locations
πŸ‡°πŸ‡·

Mi Young Lee, Wonju, Kangwon-Do, Korea, Republic of

Combination Therapy for Neovascular Age Related Macular Degeneration

Not Applicable
Withdrawn
Conditions
First Posted Date
2007-03-13
Last Posted Date
2010-02-09
Lead Sponsor
Yonsei University
Registration Number
NCT00447031
Locations
πŸ‡°πŸ‡·

Department of Ophthalmology, Yonsei University College of Medicine, Seoul, Korea, Republic of

Long-Term IOP Fluctuation and VF Progression After Triple Procedure

First Posted Date
2007-01-30
Last Posted Date
2007-01-30
Lead Sponsor
Yonsei University
Target Recruit Count
300
Registration Number
NCT00428740
Locations
πŸ‡°πŸ‡·

Yonsei University College of Medicine, Seoul, Korea, Republic of

Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy

Not Applicable
Completed
Conditions
First Posted Date
2007-01-17
Last Posted Date
2007-03-13
Lead Sponsor
Yonsei University
Target Recruit Count
20
Registration Number
NCT00423059
Locations
πŸ‡°πŸ‡·

Department of Ophthalmology, Yonsei University College of Medicine, Seoul, Korea, Republic of

Docetaxel and Epirubicin in Advanced Gastric Cancer

Phase 2
Completed
Conditions
Interventions
First Posted Date
2006-09-14
Last Posted Date
2014-03-03
Lead Sponsor
Yonsei University
Target Recruit Count
34
Registration Number
NCT00375999
Locations
πŸ‡°πŸ‡·

Yongdong Severance Hospital, Seoul, Korea, Republic of

Β© Copyright 2024. All Rights Reserved by MedPath